Abstract
SummaryThe long-awaited 2022 World Health Organization Classification of Haematolymphoid Tumours (WHO-5-HAEM) has finally been published as part of the IARC Blue Book series. This two-volume edition is significantly more comprehensive than its predecessors, reflecting the integration of extensive advancements in genetic and molecular understanding, alongside clinically relevant findings. This brief review will highlight the key changes in the classification of the most common B‑cell lymphoproliferative disorders, specifically follicular lymphomas and large B‑cell lymphomas (LBCL). It will also introduce new entities and summarize the most critical updates within these lymphoma categories.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
